Roche Diagnostics and the National Minority Quality Forum are founding partners of the Diabetes Care Project (DCP) and are currently working to expand the coalition. All partners of the DCP are committed to improving patient outcomes and advancing diabetes care and management.
About the National Minority Quality Forum
The National Minority Quality Forum is a nonprofit, nonpartisan research and educational organization dedicated to ensuring that high-risk racial and ethnic populations and communities receive optimal health care. The Forum integrates data and expertise in support of initiatives to eliminate health disparities.
For more information, please visit https://www.nmqf.org/.
About American Association of Diabetes Educators
AADE is a multi-disciplinary professional membership organization dedicated to improving diabetes care through education. With more than 12,000 professional members including nurses, dietitians, pharmacists, physicians, and others, AADE has a vast network of practitioners involved in the daily treatment of diabetes patients. Collectively, our alliances, member practitioner networks, and academic partners uniquely position AADE at the locus of change for the future treatment of diabetes.
For more information, please visit: www.diabeteseducator.org.
Alliance for Aging Research (AAR)
The private, not-for-profit Alliance for Aging Research (AAR) is the nation's leading citizen advocacy organization for improving the health and independence of Americans as they age. AAR was founded in 1986 to promote medical and behavioral research into the aging process. Since then, and as the explosion of the Senior Boom approaches, AAR has become the voice for Baby Boomer health by developing, implementing and advocating programs in research, professional and consumer health education and public policy.
AAR believes that science can help people live longer, more productive lives. AAR feels that greater access to the latest scientific information will empower people to take control of their own health, while educating them on the importance and need for further medical advances. From policy issues to consumer health programs, AAR works to generate knowledge and action on age-related issues.
For more information, please visit: https://www.agingresearch.org/.
About Roche Diabetes Care
Roche Diabetes Care is a pioneer in the development of blood glucose monitoring systems and a global leader for diabetes management systems and services. For more than 30 years, Roche has been committed to helping people with diabetes live lives that are as normal and active as possible and has been helping healthcare professionals manage their patients’ condition in an optimal way. Today, the ACCU-CHEK portfolio offers people with diabetes and healthcare professionals innovative products, services and comprehensive solutions for convenient, efficient and effective diabetes management—from blood glucose monitoring through information management to insulin delivery. The ACCU-CHEK brand encompasses blood glucose meters, infusion pumps, lancing and data management systems.
For more information, please visit www.accu-chek.com.
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche’s personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients.
In 2008, Roche had over 80,000 employees worldwide and invested almost 9 billion Swiss francs in R & D. The Group posted sales of 45.6 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan.
For more information, please visit: www.roche-diagnostics.us
Healthways is the leading provider of specialized, comprehensive solutions to help millions of people maintain or improve their health and well-being and, as a result, reduce overall costs. Healthways’ solutions are designed to help healthy individuals stay healthy, mitigate and slow the progression to disease associated with family or lifestyle risk factors and promote the best possible health for those already affected by disease. Our proven, evidence-based programs provide highly specific and personalized interventions for each individual in a population, irrespective of age or health status, and are delivered to consumers by phone, mail, internet and face-to-face interactions, both domestically and internationally. Healthways also provides a national, fully accredited complementary and alternative Health Provider Network and a national Fitness Center Network, offering convenient access to individuals who seek health services outside of, and in conjunction with, the traditional healthcare system.
For more information, please visit: www.healthways.com
With gestational diabetes, the body is not able to make and use all the insulin it needs for pregnancy. Those with gestational diabetes did not have diabetes prior to conception nor does it mean they will have diabetes after giving birth. Gestational diabetes affects about 4 percent of all pregnant women.1